NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Wednesday, March 4, 2015
Professor and Chair of Pediatrics
Department of Pediatrics
School of Medicine
Case Western Reserve University
Michael W. Konstan, MD is the Gertrude Lee Chandler Tucker Professor and Chairman of the Department of Pediatrics at Case Western Reserve University (CWRU) School of Medicine, where he also serves as the director of CWRU's CF Translational Therapeutics Development Center and CF Research Development Program. Dr. Konstan is also the Chair of Pediatrics at University Hospitals Rainbow Babies and Children's Hospital, where he also holds the Austin Ricci Chair in Pediatric Pulmonary Care and Research, and directs the LeRoy W. Matthews Cystic Fibrosis Center. |
Dr. Konstan received his B.A. and M.D. degrees from Case Western Reserve University. After completing his internship and residency in Pediatrics at The Children's Hospital of Buffalo, he returned to Case for Fellowship training in Pediatric Pulmonology. Dr. Konstan has spent his entire professional career in the care and research of patients with cystic fibrosis (CF). He and his team are among the world’s most innovative researchers in pediatric pulmonology, developing new treatments and leading the search for a cure for CF. He has led numerous national and international clinical trials of potentially new therapies for CF, and his seminal work has led to several therapies that are in use today, including the only recommended therapy for treating the lung inflammation in CF using high doses of ibuprofen
Dr. Konstan's research has been supported by grants from the Cystic Fibrosis Foundation, National Institutes of Health, and the Food and Drug Administration. He has published extensively in the medical literature, with more than 125 peer-reviewed publications and numerous book chapters and abstracts. He serves on multiple advisory boards and committees of the CF Foundation, the NIH and the FDA, all related to advancing the treatment of cystic fibrosis. He is highly sought after for presenting at major meetings both nationally and internationally, and is regarded as an expert in this disease worldwide.
Dr. Konstan has received several national awards for his accomplishments, including the Richard C. Talamo Distinguished Clinical Achievement Award from the Cystic Fibrosis Foundation, and the "All Stars Among Us" award for community service from Major League Baseball and PEOPLE magazine. He is regularly named in "Best Doctors in America."